Jailendra Singh analyst TRUIST

Currently out of the existing stock ratings of Jailendra Singh, 117 are a HOLD (44.49%), 8 are a SELL (3.04%), 138 are a BUY (52.47%).

Jailendra Singh

Work Performance Price Targets & Ratings Chart

Analyst Jailendra Singh, currently employed at TRUIST, carries an average stock price target met ratio of 52.38% that have a potential upside of 17.64% achieved within 101 days. Previously, Jailendra Singh worked at CREDIT SUISSE.

Jailendra Singh’s has documented 532 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Financial Services, Consumer Defensive sectors.

Most recent stock forecast was given on EVH, Evolent Health at 10-Nov-2025.

Wall Street Analyst Jailendra Singh

Analyst best performing recommendations are on OMI (OWENS & MINOR).
The best stock recommendation documented was for OMI (OWENS & MINOR) at 11/4/2020. The price target of $25 was fulfilled within 1 day with a profit of $1.16 (4.87%) receiving and performance score of 48.66.

Average potential price target upside

ABC AmerisourceBergen ACCD Accolade  AMWL American Well Corp CLOV Clover Health Investments Corp GDRX Goodrx Holdings  GOCO GoHealth HIMS Hims Hers Health MCK McKesson OMI Owens & Minor OSCR Oscar Health PRVA Privia Health Group TDOC Teladoc TLMD SOC Telemed TVTY Tivity Health EHTH eHealth CAH Cardinal Health CANO Cano Health ONEM 1Life Healthcare DH Definitive Healthcare Corp ONE OneSmart International Education Group CHNG Change Healthcare SLQT Selectquote AGL agilon health PINC Premier RCM R1 RCM DOCS Doximity IQV IQVIA Holdings NXGN Nextgen Healthcare PGNY Progyny ICLR ICON PLC VEEV Veeva Systems PHR Phreesia EVH Evolent Health MEDP Medpace Holdings ASTH Astrana Health

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 10-Oct-2017

$215

$40.04 (22.89%)

$187

2 years 4 months 30 days ago
(07-Aug-2023)

13/14 (92.86%)

$28.91 (15.54%)

633

Hold

Since 27-May-2022

$190

$15.04 (8.60%)

$176

2 years 5 months 3 days ago
(03-Aug-2023)

8/8 (100%)

$-0.86 (-0.45%)

433

Buy

Since 05-Aug-2021

$220

$45.04 (25.74%)

$213

2 years 5 months 3 days ago
(03-Aug-2023)

11/17 (64.71%)

$29.14 (15.27%)

326

Buy

Since 07-Jun-2023

$215

$40.04 (22.89%)

$200

2 years 5 months 3 days ago
(03-Aug-2023)

6/8 (75%)

$24.14 (12.65%)

220

Buy

Since 08-Feb-2018

$225

$50.04 (28.60%)

$184

2 years 5 months 5 days ago
(01-Aug-2023)

11/12 (91.67%)

$36.39 (19.29%)

557

Show more analysts

Please expand the browser size to see the chart

Which stock is Jailendra Singh is most bullish on?

Potential upside of $45.33 has been obtained for ICLR (ICON PLC)

Which stock is Jailendra Singh is most reserved on?

Potential downside of -$135.02 has been obtained for MEDP (MEDPACE HOLDINGS)

What Year was the first public recommendation made by Jailendra Singh?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?